| Introduction
Laparoscopic cholecystectomy, though minimally invasive, is often associated with significant pain during the immediate post operative period due to peritoneal irritation, pneumoperitoneum, and tissue handling. Opioids remain the standard for peri-operative analgesia but are linked with several adverse effects such as respiratory depression, nausea, constipation, dependence, and delayed recovery. Opioid free anaesthesia (OFA), which uses multimodal non opioid analgesics (e.g., dexmedetomidine, ketamine), aims to minimize opioid related complications while maintaining adequate analgesia. Evidence suggests OFA may reduce postoperative pain scores, opioid consumption, and PONV.
Need for the Study
Uncontrolled acute postoperative pain increases the risk of developing chronic postoperative pain. Reducing perioperative opioid use is essential to avoid long term opioid dependence and related adverse effects. Although OFA has been studied, there is limited literature comparing postoperative analgesic outcomes between OFA and opioid based anaesthesia (OBA) specifically in laparoscopic cholecystectomy. This study aims to fill this gap by evaluating postoperative analgesia, rescue analgesic requirements, and PONV incidence.
Hypothesis
Opioid free anaesthesia provides:
Lower rescue analgesic consumption
Lower postoperative VAS pain scores
Earlier PACU discharge compared to opioid based total intravenous anaesthesia.
Objectives
Primary Objective
To compare the time to first rescue analgesia between OFA and OBA groups.
Secondary Objectives
To compare total rescue analgesic consumption in the first 24 hours.
To evaluate postoperative VAS pain scores at 1, 6, 12, and 24 hours.
To assess the incidence of postoperative nausea and vomiting (PONV).
Methodology
Study Design
Randomised controlled study.
Participants
Patients aged 18 to 60 years undergoing elective laparoscopic cholecystectomy, ASA II or III, BMI less than 30 kg/m².
Exclusion Criteria
Severe systemic diseases, neuropsychiatric disorders, hemodynamic instability, drug allergy, history of opioid use or addiction, malignant hyperthermia, muscular dystrophy, electrolyte imbalance, or inability to comprehend VAS.
Randomisation
104 patients randomized into:
OFA group dexmedetomidine + ketamine
OBA group fentanyl based anaesthesia
Procedure
Standardised general anaesthesia using TCI propofol with BIS monitoring. Postoperative pain assessed via VAS. Tramadol administered if VAS more than or equal to 4.
Outcome Measures
Time to first rescue analgesic
Total 24 hour rescue analgesic dose
VAS scores
PONV incidence
Statistical Analysis
Independent t test for comparing means
Chi-square test for categorical variables
Descriptive statistics for summary values
Expected Results
OFA is expected to prolong time to first rescue analgesia, reduce total opioid requirement, improve postoperative pain scores, and decrease PONV compared to OBA. |